$1.31 Billion is the total value of Nantahala Capital Management's 124 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 28.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | Sell | ISHARES TRput | $180,184,000 | -39.2% | 1,010,000 | -40.6% | 13.81% | -28.1% |
| ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $126,820,118 | +6.4% | 1,872,160 | +3.1% | 9.72% | +25.8% |
| QURE | Buy | UNIQURE NV | $61,837,071 | +1.0% | 3,070,361 | +13.7% | 4.74% | +19.4% |
| IMAX | Buy | IMAX CORP | $58,569,870 | +42.8% | 3,053,695 | +9.2% | 4.49% | +68.9% |
| CASH | Buy | PATHWARD FINANCIAL INC | $55,593,903 | -0.8% | 1,339,935 | +3.0% | 4.26% | +17.3% |
| TA | Sell | TRAVELCENTERS OF AMERICA INC | $51,745,165 | +12.0% | 598,210 | -42.0% | 3.96% | +32.5% |
| APEN | Buy | APOLLO ENDOSURGERY INC | $45,384,208 | +12.2% | 4,575,021 | +12.8% | 3.48% | +32.7% |
| LXFR | Buy | LUXFER HLDGS PLC | $41,646,467 | +23.8% | 2,464,288 | +0.5% | 3.19% | +46.3% |
| IWM | Sell | ISHARES TRrussell 2000 etf | $34,081,536 | -71.7% | 191,040 | -72.4% | 2.61% | -66.6% |
| KROS | Sell | KEROS THERAPEUTICS INC | $31,718,371 | -16.6% | 742,819 | -6.2% | 2.43% | -1.4% |
| PTON | Buy | PELOTON INTERACTIVE INC | $27,865,136 | +46.5% | 2,457,243 | +2.6% | 2.14% | +73.2% |
| TNL | TRAVEL PLUS LEISURE CO | $24,636,377 | +7.7% | 628,479 | 0.0% | 1.89% | +27.3% | |
| RDVT | Buy | RED VIOLET INC | $23,070,150 | -21.4% | 1,310,804 | +2.8% | 1.77% | -7.0% |
| RMR | Sell | RMR GROUP INCcl a | $21,566,840 | -9.8% | 821,907 | -2.9% | 1.65% | +6.7% |
| CDXS | Buy | CODEXIS INC | $21,327,454 | +2.0% | 5,151,559 | +14.8% | 1.63% | +20.6% |
| SNDX | SYNDAX PHARMACEUTICALS INC | $20,606,890 | -17.0% | 975,705 | 0.0% | 1.58% | -1.9% | |
| APEN | APOLLO ENDOSURGERY INCcall | $19,840,000 | -0.5% | 2,000,000 | 0.0% | 1.52% | +17.6% | |
| MLHR | Sell | MILLERKNOLL INC | $19,100,975 | -9.2% | 934,033 | -6.7% | 1.46% | +7.3% |
| IMTX | IMMATICS N.V | $18,964,836 | -20.8% | 2,748,527 | 0.0% | 1.45% | -6.4% | |
| HGV | Sell | HILTON GRAND VACATIONS INC | $18,225,186 | +14.4% | 410,200 | -0.7% | 1.40% | +35.4% |
| MAX | Sell | MEDIAALPHA INCcl a | $16,283,155 | +27.5% | 1,086,993 | -15.3% | 1.25% | +50.7% |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $15,609,698 | +10.6% | 1,790,103 | -20.5% | 1.20% | +30.7% |
| VMD | Sell | VIEMED HEALTHCARE INC | $15,386,390 | +15.0% | 1,592,794 | -10.0% | 1.18% | +36.0% |
| GDEN | Sell | GOLDEN ENTMT INC | $15,376,826 | -9.9% | 353,409 | -22.5% | 1.18% | +6.5% |
| AUTL | Sell | AUTOLUS THERAPEUTICS PLCspon ads | $14,152,936 | -4.3% | 7,691,813 | -1.2% | 1.08% | +13.2% |
| DHX | Sell | DHI GROUP INC | $13,247,527 | -31.6% | 3,414,311 | -6.8% | 1.02% | -19.2% |
| AMYT | Sell | AMRYT PHARMA PLCsponsored ads | $11,967,628 | +14.0% | 820,825 | -42.9% | 0.92% | +34.9% |
| Sell | DARIOHEALTH CORP | $9,964,250 | -5.6% | 2,418,507 | -2.0% | 0.76% | +11.7% | |
| ALTG | Sell | ALTA EQUIPMENT GROUP INC | $9,939,646 | -36.6% | 627,107 | -47.3% | 0.76% | -25.0% |
| RH | RHcall | $9,742,000 | -8.8% | 40,000 | 0.0% | 0.75% | +7.8% | |
| HLF | Sell | HERBALIFE NUTRITION LTDcall | $9,660,000 | -25.2% | 600,000 | -30.9% | 0.74% | -11.6% |
| RMBL | Buy | RUMBLEON INC | $9,483,864 | -1.6% | 1,564,994 | +5.1% | 0.73% | +16.3% |
| PAYO | Buy | PAYONEER GLOBAL INC | $9,486,663 | +23.8% | 1,510,615 | +39.2% | 0.73% | +46.3% |
| RDI | Sell | READING INTL INCcl a | $9,411,009 | +16.8% | 2,895,695 | -0.4% | 0.72% | +38.1% |
| DXPE | DXP ENTERPRISES INC | $9,101,383 | -2.3% | 338,090 | 0.0% | 0.70% | +15.4% | |
| PTON | Sell | PELOTON INTERACTIVE INCcall | $8,845,200 | -18.6% | 780,000 | -43.0% | 0.68% | -3.7% |
| RH | Buy | RH | $8,782,413 | +14.1% | 36,060 | +25.2% | 0.67% | +34.9% |
| Buy | AURA BIOSCIENCES INC | $7,827,179 | -6.7% | 843,446 | +5.6% | 0.60% | +10.3% | |
| QURE | Sell | UNIQURE NVcall | $7,808,278 | -71.0% | 387,700 | -67.4% | 0.60% | -65.7% |
| ZM | ZOOM VIDEO COMMUNICATIONS INcall | $7,384,000 | +9.0% | 100,000 | 0.0% | 0.57% | +28.9% | |
| DHC | Buy | DIVERSIFIED HEALTHCARE TR | $7,274,660 | +166.8% | 5,388,637 | +27.8% | 0.56% | +214.7% |
| New | CVENT HOLDING CORP | $7,064,200 | – | 845,000 | +100.0% | 0.54% | – | |
| ESTA | ESTABLISHMENT LABS HLDGS INCcall | $6,774,000 | +3.2% | 100,000 | 0.0% | 0.52% | +22.1% | |
| Buy | VENTYX BIOSCIENCES INC | $6,454,478 | +24.6% | 192,671 | +21.9% | 0.50% | +47.3% | |
| CDTX | Buy | CIDARA THERAPEUTICS INC | $6,006,634 | +81.8% | 4,729,633 | +8.3% | 0.46% | +115.0% |
| FBIO | Sell | FORTRESS BIOTECH INC | $5,672,658 | +8.7% | 6,917,876 | -13.2% | 0.44% | +28.7% |
| BVS | Buy | BIOVENTUS INC | $5,535,612 | -33.1% | 5,173,469 | +63.3% | 0.42% | -20.9% |
| MDXG | Buy | MIMEDX GROUP INC | $5,214,231 | +63.4% | 1,529,100 | +33.3% | 0.40% | +93.2% |
| CRMT | Buy | AMERICAS CAR-MART INC | $5,074,985 | +368.2% | 64,070 | +327.1% | 0.39% | +455.7% |
| IMAX | Sell | IMAX CORPcall | $4,795,000 | -85.1% | 250,000 | -88.6% | 0.37% | -82.4% |
| SSKN | STRATA SKIN SCIENCES INC | $4,651,594 | +34.0% | 4,393,685 | 0.0% | 0.36% | +58.2% | |
| PWP | Buy | PERELLA WEINBERG PARTNERS | $4,598,167 | -7.0% | 505,293 | +110.7% | 0.35% | +10.0% |
| LYRA | LYRA THERAPEUTICS INC | $4,463,868 | -36.0% | 2,220,830 | 0.0% | 0.34% | -24.3% | |
| RNG | RINGCENTRAL INCcl a | $4,220,867 | -13.4% | 137,622 | 0.0% | 0.32% | +2.2% | |
| PNT | POINT BIOPHARMA GLOBAL INC | $4,159,829 | -0.3% | 572,191 | 0.0% | 0.32% | +18.1% | |
| PAR TECHNOLOGY CORPnote 2.875% 4/1 | $4,047,740 | +13.5% | 3,785,000 | 0.0% | 0.31% | +34.2% | ||
| Buy | ABEONA THERAPEUTICS INC | $4,028,864 | -3.8% | 1,428,675 | +423.8% | 0.31% | +14.0% | |
| ILPT | New | INDUSTRIAL LOGISTICS PPTYS T | $3,869,072 | – | 1,260,284 | +100.0% | 0.30% | – |
| EHTH | New | EHEALTH INC | $3,744,000 | – | 400,000 | +100.0% | 0.29% | – |
| AGS | Buy | PLAYAGS INC | $3,550,068 | +212.8% | 496,513 | +123.1% | 0.27% | +267.6% |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $3,516,172 | – | 15,700 | +100.0% | 0.27% | – |
| IDYA | IDEAYA BIOSCIENCES INC | $3,480,280 | -24.4% | 253,480 | 0.0% | 0.27% | -10.7% | |
| VKTX | New | VIKING THERAPEUTICS INC | $3,341,655 | – | 200,700 | +100.0% | 0.26% | – |
| Sell | APTOSE BIOSCIENCES INC | $3,186,544 | -9.2% | 4,978,975 | -17.7% | 0.24% | +7.0% | |
| MED | MEDIFAST INC | $3,110,100 | -10.1% | 30,000 | 0.0% | 0.24% | +6.2% | |
| New | JASPER THERAPEUTICS INC | $3,056,102 | – | 1,688,454 | +100.0% | 0.23% | – | |
| AAN | THE AARONS COMPANY INC | $2,787,606 | -19.2% | 288,572 | 0.0% | 0.21% | -4.5% | |
| OPTN | OPTINOSE INC | $2,798,500 | +4.3% | 1,450,000 | 0.0% | 0.21% | +23.0% | |
| TELA | Sell | TELA BIO INC | $2,724,819 | -32.1% | 256,092 | -26.6% | 0.21% | -19.6% |
| ENVA | ENOVA INTL INC | $2,365,898 | +15.8% | 53,250 | 0.0% | 0.18% | +37.1% | |
| MACK | Sell | MERRIMACK PHARMACEUTICALS IN | $2,350,659 | -2.3% | 191,266 | -8.9% | 0.18% | +15.4% |
| KRE | New | SPDR SER TRcall | $2,193,000 | – | 50,000 | +100.0% | 0.17% | – |
| SRL | Sell | SCULLY ROYALTY LTD | $2,080,497 | -14.6% | 310,522 | -1.7% | 0.16% | +0.6% |
| DYN | New | DYNE THERAPEUTICS INC | $2,060,940 | – | 178,901 | +100.0% | 0.16% | – |
| NPCE | Sell | NEUROPACE INC | $1,976,292 | +205.9% | 425,925 | -1.8% | 0.15% | +259.5% |
| AVTE | Buy | AEROVATE THERAPEUTICS INC | $1,916,150 | +316.5% | 95,000 | +505.1% | 0.15% | +390.0% |
| Sell | DISC MEDICINE INC | $1,897,310 | -38.1% | 89,538 | -45.0% | 0.14% | -27.1% | |
| RILY | Sell | B. RILEY FINANCIAL INC | $1,774,943 | -24.0% | 62,520 | -8.5% | 0.14% | -9.9% |
| DAKT | DAKTRONICS INC | $1,656,700 | +101.1% | 292,187 | 0.0% | 0.13% | +139.6% | |
| ADCT | Buy | ADC THERAPEUTICS SA | $1,638,000 | +75.3% | 840,000 | +245.3% | 0.13% | +106.6% |
| Buy | SOLENO THERAPEUTICS INC | $1,496,639 | +25.1% | 699,364 | +15.8% | 0.12% | +47.4% | |
| ANEB | ANEBULO PHARMACEUTICALS INC | $1,482,112 | +19.7% | 511,073 | 0.0% | 0.11% | +42.5% | |
| RZLT | Buy | REZOLUTE INC | $1,477,644 | -0.7% | 769,606 | +7.1% | 0.11% | +17.7% |
| CVNA | CARVANA COcall | $1,468,500 | +106.5% | 150,000 | 0.0% | 0.11% | +145.7% | |
| IMTXW | IMMATICS N.V*w exp 07/01/202 | $1,419,985 | -42.6% | 986,101 | 0.0% | 0.11% | -31.9% | |
| Buy | AVALO THERAPEUTICS INC | $1,415,477 | -48.1% | 808,844 | +49.6% | 0.11% | -39.0% | |
| EHTH | New | EHEALTH INCcall | $1,390,896 | – | 148,600 | +100.0% | 0.11% | – |
| SELB | New | SELECTA BIOSCIENCES INC | $1,390,000 | – | 1,000,000 | +100.0% | 0.11% | – |
| UNICYCIVE THERAPEUTICS INC | $1,359,574 | +288.9% | 647,416 | 0.0% | 0.10% | +352.2% | ||
| TSHA | Sell | TAYSHA GENE THERAPIES INC | $1,350,706 | -80.1% | 1,722,400 | -42.6% | 0.10% | -76.3% |
| AGLE | Sell | AEGLEA BIOTHERAPEUTICS INC | $1,321,823 | -36.3% | 4,558,012 | -1.2% | 0.10% | -24.6% |
| Sell | AKUMIN INC | $1,283,062 | -19.1% | 1,886,856 | -14.5% | 0.10% | -4.9% | |
| WNC | Sell | WABASH NATL CORPput | $1,229,500 | -18.4% | 50,000 | -25.0% | 0.09% | -4.1% |
| New | STRUCTURE THERAPEUTICS INCsponsored ads | $1,189,500 | – | 50,000 | +100.0% | 0.09% | – | |
| CYTK | Buy | CYTOKINETICS INC | $1,055,700 | +379.8% | 30,000 | +524.7% | 0.08% | +478.6% |
| SRTS | New | SENSUS HEALTHCARE INC | $964,100 | – | 185,048 | +100.0% | 0.07% | – |
| ACER | Sell | ACER THERAPEUTICS INC | $912,571 | -70.3% | 1,203,126 | -1.9% | 0.07% | -64.8% |
| SCYX | New | SCYNEXIS INC | $900,000 | – | 300,000 | +100.0% | 0.07% | – |
| SGRP | Buy | SPAR GROUP INC | $898,586 | +28.4% | 696,578 | +29.4% | 0.07% | +53.3% |
| LNDC | New | LIFECORE BIOMEDICAL INC | $734,992 | – | 194,700 | +100.0% | 0.06% | – |
| AMRX | New | AMNEAL PHARMACEUTICALS INC | $695,000 | – | 500,000 | +100.0% | 0.05% | – |
| New | AYTU BIOPHARMA INC | $608,346 | – | 271,595 | +100.0% | 0.05% | – | |
| IDWM | Sell | IDW MEDIA HLDGS INCcl b | $592,226 | -24.6% | 822,537 | -1.6% | 0.04% | -11.8% |
| ANGN | Sell | ANGION BIOMEDICA CORP | $540,509 | -35.5% | 982,743 | -4.9% | 0.04% | -24.1% |
| Sell | HYPERFINE INC | $530,520 | +15.9% | 368,417 | -32.4% | 0.04% | +36.7% | |
| KROS | Sell | KEROS THERAPEUTICS INCcall | $525,210 | -73.9% | 12,300 | -70.6% | 0.04% | -69.2% |
| New | EBET INC | $438,319 | – | 1,065,432 | +100.0% | 0.03% | – | |
| Sell | LUCID DIAGNOSTICS INC | $376,796 | -0.9% | 261,664 | -6.4% | 0.03% | +16.0% | |
| TACT | Sell | TRANSACT TECHNOLOGIES INC | $376,284 | -9.4% | 60,789 | -7.5% | 0.03% | +7.4% |
| Sell | JOURNEY MED CORP | $333,400 | -23.2% | 212,357 | -6.0% | 0.03% | -7.1% | |
| CUE | CUE BIOPHARMA INC | $333,070 | +25.3% | 93,297 | 0.0% | 0.03% | +52.9% | |
| XGN | Sell | EXAGEN INC | $322,250 | -8.4% | 132,613 | -9.5% | 0.02% | +8.7% |
| BMTX | Sell | BM TECHNOLOGIES INC | $278,826 | -82.6% | 79,212 | -74.3% | 0.02% | -79.8% |
| New | EARGO INC | $252,729 | – | 54,002 | +100.0% | 0.02% | – | |
| CRIS | Sell | CURIS INC | $137,446 | -68.6% | 230,614 | -71.0% | 0.01% | -60.7% |
| IMAC | Sell | IMAC HLDGS INC | $148,731 | -36.5% | 1,040,075 | -11.4% | 0.01% | -26.7% |
| RFL | RAFAEL HLDGS INC | $112,651 | -17.1% | 72,678 | 0.0% | 0.01% | 0.0% | |
| New | LUCY SCIENTIFIC DISCOVERY IN | $105,380 | – | 95,800 | +100.0% | 0.01% | – | |
| FULC | Sell | FULCRUM THERAPEUTICS INC | $60,904 | -98.3% | 21,370 | -95.7% | 0.01% | -97.9% |
| GAIA | New | GAIA INC NEWcl a | $64,340 | – | 23,144 | +100.0% | 0.01% | – |
| CBIO | Sell | CATALYST BIOSCIENCES INC | $33,209 | -85.6% | 160,430 | -63.4% | 0.00% | -80.0% |
| GUARDFORCE AI CO LTD*w exp 10/01/202 | $30,856 | +900.5% | 154,205 | 0.0% | 0.00% | – | ||
| TC BIOPHARM HOLDINGS PLC*w exp 02/08/202 | $23,506 | +11.7% | 235,294 | 0.0% | 0.00% | +100.0% | ||
| QUALTEK SERVICES INC*w exp 02/14/202 | $2,921 | -26.2% | 96,244 | 0.0% | 0.00% | – | ||
| HERAW | Exit | FTAC HERA ACQUISITION CORP*w exp 02/28/202 | $0 | – | -222,949 | -100.0% | 0.00% | – |
| SFT | Exit | SHIFT TECHNOLOGIES INCcl a | $0 | – | -200,000 | -100.0% | -0.00% | – |
| Exit | KINTARA THERAPEUTICS INC | $0 | – | -11,901 | -100.0% | -0.01% | – | |
| Exit | CYREN LTD | $0 | – | -116,214 | -100.0% | -0.01% | – | |
| SGU | Exit | STAR GROUP L Punit ltd partnr | $0 | – | -12,681 | -100.0% | -0.01% | – |
| IDN | Exit | INTELLICHECK INC | $0 | – | -124,594 | -100.0% | -0.02% | – |
| NAUT | Exit | NAUTILUS BIOTECHNOLOGY INC | $0 | – | -289,845 | -100.0% | -0.03% | – |
| LQDA | Exit | LIQUIDIA CORPORATION | $0 | – | -146,792 | -100.0% | -0.06% | – |
| DS | Exit | DRIVE SHACK INC | $0 | – | -6,500,000 | -100.0% | -0.07% | – |
| VRM | Exit | VROOM INCcall | $0 | – | -1,500,000 | -100.0% | -0.10% | – |
| Exit | WEBER INCcl a | $0 | – | -500,000 | -100.0% | -0.26% | – | |
| PRDO | Exit | PERDOCEO ED CORPput | $0 | – | -500,000 | -100.0% | -0.45% | – |
| CNCE | Exit | CONCERT PHARMACEUTICALS INC | $0 | – | -1,732,388 | -100.0% | -0.66% | – |
| PAYA | Exit | PAYA HOLDINGS INC | $0 | – | -2,472,352 | -100.0% | -1.26% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
About Nantahala Capital Management
Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.
Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.
Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.
Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 40 | Q1 2023 | 27.2% |
| CODEXIS INC | 40 | Q1 2023 | 3.9% |
| SCIENTIFIC GAMES CORP | 34 | Q3 2022 | 5.3% |
| DOVER MOTORSPORTS INC | 34 | Q3 2021 | 0.5% |
| PATHWARD FINANCIAL INC | 33 | Q1 2023 | 4.3% |
| QAD INC | 32 | Q3 2021 | 2.6% |
| SCIENTIFIC GAMES CORP | 31 | Q4 2021 | 7.7% |
| DOLBY LABORATORIES INC | 31 | Q4 2020 | 5.6% |
| GOLDEN ENTMT INC | 31 | Q1 2023 | 2.1% |
| LINCOLN EDL SVCS CORP | 31 | Q4 2021 | 0.7% |
View Nantahala Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. | February 14, 2023 | 1,359,687 | 7.9% |
| Acer Therapeutics Inc. | February 14, 2023 | 1,226,191 | 7.5% |
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 4,611,302 | 7.5% |
| AKUMIN INC. | February 14, 2023 | 2,206,960 | 2.5% |
| ALTA EQUIPMENT GROUP INC. | February 14, 2023 | 1,188,985 | 3.7% |
| Apollo Endosurgery, Inc. | February 14, 2023 | 4,056,627 | 9.9% |
| Aptose Biosciences Inc. | February 14, 2023 | 6,052,867 | 6.6% |
| Autolus Therapeutics plc | February 14, 2023 | 7,782,018 | 4.7% |
| Avalo Therapeutics, Inc. | February 14, 2023 | 654,674 | 7.0% |
| Bioventus Inc. | February 14, 2023 | 3,168,574 | 5.1% |
View Nantahala Capital Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D | 2023-05-26 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
View Nantahala Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.